Apr 04, 2019
Canada Halts Sales of Cancer-Linked Breast Implants, as Global Scrutiny Grows
A growing wave of regulators are reconsidering the safety of textured breast implants that have been associated with a higher risk of cancer.
A growing wave of regulators are reconsidering the safety of textured breast implants that have been associated with a higher risk of cancer.
French health authorities have informed manufacturers of a sweeping and historic ban on two categories of breast implants.
On the eve of a hearing about breast implant safety, the U.S. regulator revealed it has long known about vastly more complications than previously disclosed.
There is growing international concern over breast implant safety, particularly due to a rare cancer that occurs most often in implants with rough surfaces.
A committee convened by France’s medical device safety authority has stopped short of calling for the total removal of textured breast implants.
A specific type of Allergan breast implant that has been linked to an emerging form of cancer has been recalled in Europe, French authorities announced on Tuesday.
A new survey reconfirms the Implant Files investigation findings, with patients saying they were not informed of device-related risks.
Manufacturers fought to get implants back on the market. Regulators gave in. Now thousands of patients are paying the price.
The ruling excluded information on the grounds of protecting trade secrets as Le Monde journalists continue to call for press freedom.
ICIJ received more than 3,500 responses from people affected by the medical device industry in 50 countries, bringing to life the personal cost of implants that fail.